Showing 17,001 - 17,020 results of 106,247 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( e ((non decrease) OR (point decrease)) ))', query time: 1.35s Refine Results
  1. 17001

    Data_Sheet_1_MiR-30c-5p/ATG5 Axis Regulates the Progression of Parkinson’s Disease.xlsx by Li Zhang (8200)

    Published 2021
    “…MiR-30c-5p antagomiR attenuated the decrease of ATG5 in PD mice. …”
  2. 17002
  3. 17003
  4. 17004
  5. 17005
  6. 17006
  7. 17007
  8. 17008
  9. 17009
  10. 17010

    Image_5_Extensive Healthy Donor Age/Gender Adjustments and Propensity Score Matching Reveal Physiology of Multiple Sclerosis Through Immunophenotyping.tif by Paavali A. Hannikainen (9698444)

    Published 2020
    “…</p><p>The goals of this blinded training and validation study of MS patients and embedded controls, representing 1,240 prospectively acquired paired CSF/blood samples from 588 subjects was (1) to define physiological age-/gender-related changes in CSF cells, (2) to define/validate cellular abnormalities in blood and CSF of untreated MS through disease duration (DD) and determine which are MS-specific, and (3) to compare effect(s) of low-efficacy (i.e., interferon-beta [IFN-beta] and glatiramer acetate [GA]) and high-efficacy drugs (i.e., natalizumab, daclizumab, and ocrelizumab) on MS-related cellular abnormalities using propensity score matching.…”
  11. 17011
  12. 17012
  13. 17013
  14. 17014
  15. 17015
  16. 17016

    Dose- and time-dependent response of <i>M</i>. <i>aeruginosa</i> fluorescence to H<sub>2</sub>O<sub>2</sub> exposure. by Emma T. Brentjens (17295999)

    Published 2023
    “…In contrast, the percentage of cells treated with low dose (7.5 μg/mL) H<sub>2</sub>O<sub>2</sub> found in the control region decreased each day and remained around 30% on day 8.…”
  17. 17017
  18. 17018
  19. 17019
  20. 17020